Influence

June 2025

• 6/11 - Health care workforce recovery after the end of the COVID-19 emergency

May 2025

• 5/16 - IU Health and Regenstrief Institute Quarterly Networking Event

• 5/7 - Implications of Increased Medicare Advantage Enrollment for Access to Kidney Transplant Waitlisting

• 5/2 - Development of Common Data Elements for Organ Transplantation

April 2025

• 4/24 - Supply, demand, and a growing US kidney transplant waiting list

• 4/21 - Impact of Pre-Existing Frailty on Cardiotoxicity Among Breast Cancer Patients Receiving Adjuvant Therapy

March 2025

• 3/19 - Screening for Food Insecurity: US Preventive Services Task Force Recommendation Statement

• 3/8 - Implicit Racial Bias and Unintentional Harm in Vascular Care

February 2025

• 2/28 - Predicting Alzheimer’s disease subtypes and understanding their molecular characteristics in living patients with transcriptomic trajectory profiling

January 2025

• 1/22 - AGA Institute Quality Indicator Development for Irritable Bowel Syndrome

• 1/15 - Mental Health Utilization Among Transgender Veterans

• 1/14 - Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement

• 1/10 - Asthma Among Children With Primary Ciliary Dyskinesia

December 2024

• 12/23 - Outpatient Dermatology Productivity Measures by Patient Race, Sex, and Age

• 12/17 - Regenstrief researcher on author list for 1 of JAMA’s 2024 most viewed papers

• 12/11 - Is the Multitarget Stool DNA Test Just a Better “FIT” for Colorectal Cancer Screening?

• 12/4 - Influenza vaccine effectiveness against hospitalizations and emergency department or urgent care encounters for children, adolescents, and adults during the 2023-2024 season, United States

• 12/1 - Optimal Transport-Based Transcriptomic Mapping Revealed Atypical Disease Progression Subtypes in Living Alzheimer’s Disease Patients

November 2024

• 11/19 - Regenstrief Institute researcher appointed associate dean for research at IU Indianapolis Fairbanks School of Public Health

• 11/18 - Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation

• 11/13 - AMIA honors Regenstrief researcher with leadership award

• 11/11 - Regenstrief researchers share international conference stage

October 2024

• 10/29 - FDA approves Cologuard Plus™ test; Regenstrief researcher principal investigator for related study

• 10/25 - Regenstrief president participates in media panel with national experts

• 10/25 - Long-term outcomes after treatment of delirium during critical illness with antipsychotics (MIND-USA): a randomised, placebo-controlled, phase 3 trial

• 10/1 - Regenstrief Institute researcher highlights qualitative outcomes from breast cancer study at international conference

September 2023

• 9/1 - Regenstrief researcher named chair of quality committee of one of nation’s largest medical professional organizations

May 2023

• 5/15 - Regenstrief researcher featured speaker at UsAgainstAlzheimer’s event in Washington, DC

April 2023

• 4/28 - Study shows improvement for female population typically with low cancer screening rates

October 2022

• 10/25 - Texas expert discusses mental health struggles for patients in Lone Star State as well as Indiana 

August 2022

• 8/31 - COOPERATE: Regenstrief and VA Research Scientists addressing health disparity at the patient level

• 8/23 - Regenstrief research scientist 1 of 33 NIA small business mentors

May 2022

• 5/17 - Regenstrief expert visits Kenya: Helps extend impact of AMPATH, sees results of Regenstrief long-term mentoring and success in resource-constrained environments

• 5/3 - Regenstrief researcher participates in expert panel discussion on life sciences and business climate

April 2022

• 4/18 - Research from Regenstrief gastroenterologist makes impact; article recognized by professional journal as 1 of most widely cited for 2020-2021

• 4/15 - Pandemic leads to maturation of real-time science: Regenstrief researchers lead the way in real-world data analysis

• 4/7 - Regenstrief expert helps identify implementation strategies to improve cirrhosis care

March 2022

• 3/31 - Regenstrief researcher will be part of life sciences expert panel

• 3/21 - Revolutionizing research through pragmatic trials

February 2022

• 2/16 - ‘Memory loss is not normal aging’ — Regenstrief scientist highlights challenges of living with dementia

January 2022

• 1/28 - Regenstrief expert applies novel analysis method in study measuring program implementation success

December 2021

• 12/29 - Experts provide context to data as Omicron surges

• 12/20 - Data from the Regenstrief COVID-19 dashboard informs decisions and addresses health disparities

• 12/10 - Computerized tools provide golden opportunities for clinical decision support in team care

• 12/2 - First study to qualitatively describe primary care provider experience with chronic cough

November 2021

• 11/4 - Regenstrief data experts contribute to NEJM, CDC COVID-19 papers

• 11/1 - Regenstrief scientist highlights benefits of gene-specific approaches to colon cancer surveillance

October 2021

• 10/27 - Regenstrief research scientist co-authors national editorial to improve dementia care

September 2021

• 9/10 - Regenstrief CEO co-authors AHRQ blog calling for action to achieve health equity

• 9/9 - Regenstrief research scientist: Possibility of COVID, flu “twindemic” very real